WE ARE NOT JUST IMAGINING THE FUTURE – WE DO CREATE IT!

July 6, 2019

Author: Acteropharma

ACTERO pharmaceutical company is honored to announce the launch of its new scientific product in the field, The Journal of Current Oncology!

As the first national English oncology journal, this eclectic review provides you cutting-edge findings in different scopes of clinical oncology collected from top ranking journals and well-known international oncology seminars in order to keep you aware of the recent advancements in the field.
As the medical forefronts of the oncology realm which have always conferred credit to us, we hope such scientific work can open a promising avenue to gain the novel insights in your practice in cancer therapy and also better help us persevere to contribute something elegant to the medical society.

Actero is a pharmaceutical company specialized in high-quality oncology products and has over 15 products under development or pending Ministry of Health approval.

Last News

Actero Men's Health Cup
January 18, 2025

Author:

Acteropharma
On the occasion of Movember and with the aim of raising awareness about men’s health, Actero organized a futsal tournament among pharmacies. This sports event, known as the “Men’s Health Cup,” saw widespread participation from various teams across the country and successfully highlighted the importance of men’s health issues.
hemato 2024
November 17, 2024

Author:

Acteropharma
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital, Tehran, alongside many experienced professors and colleagues from the Blood and Oncology Department.
Uro-Onco-2024
September 25, 2024

Author:

Acteropharma
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital